 | • レポートコード：MRC2-11QY12367 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別感染症治療の競争状況、市場シェア ・世界の感染症治療市場：種類別市場規模 2015年-2020年（抗菌、抗真菌薬、抗ウイルス薬） ・世界の感染症治療市場：種類別市場規模予測 2021年-2026年（抗菌、抗真菌薬、抗ウイルス薬） ・世界の感染症治療市場：用途別市場規模 2015年-2020年（病院・クリニック、小売薬局） ・世界の感染症治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、小売薬局） ・北米の感染症治療市場分析：米国、カナダ ・ヨーロッパの感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの感染症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Roche、Pfizer、GlaxoSmithKline、AstraZeneca、Novartis、Sanofi、Mylan ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.
Market Analysis and Insights: Global Infectious Disease Treatment Market
The global Infectious Disease Treatment market size is projected to reach US$ 50120 million by 2026, from US$ 47390 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Infectious Disease Treatment Scope and Market Size
Infectious Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Roche
Pfizer
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi
Mylan
Market segment by Type, the product can be split into
Antibacterial
Antifungal Drugs
Antiviral Drugs
Market segment by Application, split into
Hospitals & Clinics
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Infectious Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibacterial
1.4.3 Antifungal Drugs
1.4.4 Antiviral Drugs
1.5 Market by Application
1.5.1 Global Infectious Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Treatment Market Perspective (2015-2026)
2.2 Global Infectious Disease Treatment Growth Trends by Regions
2.2.1 Infectious Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infectious Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Treatment Players by Market Size
3.1.1 Global Top Infectious Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Treatment Market Concentration Ratio
3.2.1 Global Infectious Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Treatment Revenue in 2019
3.3 Infectious Disease Treatment Key Players Head office and Area Served
3.4 Key Players Infectious Disease Treatment Product Solution and Service
3.5 Date of Enter into Infectious Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Infectious Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Infectious Disease Treatment Market Size by Application (2015-2020)
5.2 Global Infectious Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Infectious Disease Treatment Market Size (2015-2020)
6.2 Infectious Disease Treatment Key Players in North America (2019-2020)
6.3 North America Infectious Disease Treatment Market Size by Type (2015-2020)
6.4 North America Infectious Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Infectious Disease Treatment Market Size (2015-2020)
7.2 Infectious Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Infectious Disease Treatment Market Size (2015-2020)
8.2 Infectious Disease Treatment Key Players in China (2019-2020)
8.3 China Infectious Disease Treatment Market Size by Type (2015-2020)
8.4 China Infectious Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Infectious Disease Treatment Market Size (2015-2020)
9.2 Infectious Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Infectious Disease Treatment Market Size (2015-2020)
10.2 Infectious Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Infectious Disease Treatment Market Size (2015-2020)
11.2 Infectious Disease Treatment Key Players in India (2019-2020)
11.3 India Infectious Disease Treatment Market Size by Type (2015-2020)
11.4 India Infectious Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Infectious Disease Treatment Market Size (2015-2020)
12.2 Infectious Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Infectious Disease Treatment Introduction
13.1.4 Merck Revenue in Infectious Disease Treatment Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Infectious Disease Treatment Introduction
13.2.4 Roche Revenue in Infectious Disease Treatment Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Infectious Disease Treatment Introduction
13.3.4 Pfizer Revenue in Infectious Disease Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Infectious Disease Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Infectious Disease Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Infectious Disease Treatment Introduction
13.5.4 AstraZeneca Revenue in Infectious Disease Treatment Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Infectious Disease Treatment Introduction
13.6.4 Novartis Revenue in Infectious Disease Treatment Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Infectious Disease Treatment Introduction
13.7.4 Sanofi Revenue in Infectious Disease Treatment Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Mylan
13.8.1 Mylan Company Details
13.8.2 Mylan Business Overview
13.8.3 Mylan Infectious Disease Treatment Introduction
13.8.4 Mylan Revenue in Infectious Disease Treatment Business (2015-2020)
13.8.5 Mylan Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Infectious Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Treatment Revenue
Table 3. Ranking of Global Top Infectious Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibacterial
Table 6. Key Players of Antifungal Drugs
Table 7. Key Players of Antiviral Drugs
Table 8. Global Infectious Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Infectious Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Infectious Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Infectious Disease Treatment Market Share by Regions (2015-2020)
Table 12. Global Infectious Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Infectious Disease Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Infectious Disease Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Infectious Disease Treatment Players
Table 19. Global Infectious Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Infectious Disease Treatment Market Share by Players (2015-2020)
Table 21. Global Top Infectious Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Treatment as of 2019)
Table 22. Global Infectious Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Infectious Disease Treatment Product Solution and Service
Table 25. Date of Enter into Infectious Disease Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Infectious Disease Treatment Market Size Share by Type (2015-2020)
Table 29. Global Infectious Disease Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Infectious Disease Treatment Market Size Share by Application (2015-2020)
Table 31. Global Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Infectious Disease Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 35. North America Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Infectious Disease Treatment Market Share by Type (2015-2020)
Table 37. North America Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Infectious Disease Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 41. Europe Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Infectious Disease Treatment Market Share by Type (2015-2020)
Table 43. Europe Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Infectious Disease Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 47. China Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Infectious Disease Treatment Market Share by Type (2015-2020)
Table 49. China Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Infectious Disease Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 53. Japan Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Infectious Disease Treatment Market Share by Type (2015-2020)
Table 55. Japan Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Infectious Disease Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 59. Southeast Asia Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Infectious Disease Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Infectious Disease Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 65. India Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Infectious Disease Treatment Market Share by Type (2015-2020)
Table 67. India Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Infectious Disease Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Infectious Disease Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Infectious Disease Treatment Market Share (2019-2020)
Table 71. Central & South America Infectious Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Infectious Disease Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Infectious Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Infectious Disease Treatment Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Product
Table 98. AstraZeneca Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 99. AstraZeneca Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Product
Table 103. Novartis Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 104. Novartis Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Product
Table 108. Sanofi Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 109. Sanofi Recent Development
Table 110. Mylan Business Overview
Table 111. Mylan Product
Table 112. Mylan Company Details
Table 113. Mylan Revenue in Infectious Disease Treatment Business (2015-2020) (Million US$)
Table 114. Mylan Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antibacterial Features
Figure 3. Antifungal Drugs Features
Figure 4. Antiviral Drugs Features
Figure 5. Global Infectious Disease Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Infectious Disease Treatment Report Years Considered
Figure 9. Global Infectious Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Infectious Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Infectious Disease Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Infectious Disease Treatment Market Share by Players in 2019
Figure 14. Global Top Infectious Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Infectious Disease Treatment Revenue in 2019
Figure 16. North America Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Infectious Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…- 感染症治療薬の世界市場（～2026年） Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them. Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of in…
- IVD感染症の世界市場（～2026年） In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.). Geographically, North America is the world's largest extracorporeal diagnostic market. Europe and the United S…
- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…